464280.KQ

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - General

DCF fair valuemodel estimate

Intrinsic value

$14530.11

Price

$5550.00

Implied upside

+162%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
464280.KQTdspharm	$5550.00	+0.00%	$29.4B	—
000220.KSYuyu Pharma, Inc.	$3820.00	-0.26%	$60.2B	—
000227.KSYuyu Pharma, Inc.	$7650.00	-1.42%	$56.9B	—
002630.KSORIENT BIO Inc.	$913.00	+8.69%	$54.1B	—
004720.KSPharmGen Science, Inc.	$2885.00	-2.86%	$63.2B	—
017180.KSMYUNGMOON Pharm co.,Ltd	$1277.00	-2.37%	$42.7B	—
118000.KSMetacare Co., Ltd.	$1267.00	-1.32%	$21.8B	—

Source: Financial Modeling Prep · peers by sector/industry

Tdspharm

Established on November 11, 2002, TDS Pharm Co. Ltd. is headquartered in Seongnam-si, South Korea, and specializes in the creation and manufacturing of transdermal drug delivery solutions. Their offerings include items such as cataplasma, plasta, fucidin band, and various prescription pharmaceuticals.

tdspharm.com

Employees: 96
IPO / List date: Aug 21, 2024
HQ: KR

Held by traders on TradeandTell

No one on the platform currently holds 464280.KQ.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 464280.KQ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 464280.KQ yet.